K+8

ANDA 70998, held by Future Pak. Potassium Chloride.

As of Nov 15, 2026, ANDA 70998 (K+8), held by Future Pak, was first approved by FDA on Jan 25, 1993, with 2 approved supplements and 0 published complete response letters.

First approved: Jan 25, 1993
Supplements approved: 2
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 3 submissions below

Date	Submission	Status	Documents
Jan 25, 1993	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
K+88MEQ · tablet, extended release;oral	Potassium Chloride	Discontinued

All 3 submissions, including labeling and manufacturing supplements


Jun 23, 1995	Supplement 6Manufacturing	Approved	None posted
Jun 23, 1995	Supplement 9Manufacturing	Approved	None posted
Jan 25, 1993	Original application	Approved	None posted

Identifiers

Application: ANDA 70998
Drugs@FDA: Overview at FDA
Company: Future Pak

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters

K+8